Skip to main content

Search
Gastroenterology, Hepatology and Nutrition

Research Funding

|

Research Funding

Grant TitleGrantorAmountAward Date
David L. Suskind, MDFecal Microbial Therapy in Inflammatory Bowel DiseaseAcademic Enrichment Fund $$20,000 2012
Ghassan T. Wahbeh, MDA Phase 2, open-label, multicenter study to assess the safety and efficacy of certolizumab pegol in children and adolescents with active Crohn’s disease (NURTURE Study) UCB 2010
Ghassan T. Wahbeh, MDGenome-Wide Association (GWA) identified predictors of response to Anti-TNFα Therapy in Pediatric IBDNIH NIDDK funding 2010
Simon Horslen, MB ChBChildhood Liver Disease Research and Education Network Clinical Center in SeattleRoleNIH/NIDDK July 1, 2009
Simon Horslen, MB ChBPilot study of the safety and immunogenicity of a rotavirus vaccine in infants at risk for intestinal failureThrasher Research FundMay 14, 2009
Karen MurrayChildhood Liver Disease Research and Education Network Clinical Center in SeattleNIH NIDDK $1,557,754.00Jan. 1, 2009
Karen Murray, MDLimited Competition: Continuation of the Non-alcoholic Steatohepatitis Clinical Research Network (NASH CRN)NIH $225,207.00Jan. 1, 2009
Karen Murray, MDA Phase 3, Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Adolescents with Chronic Hepatitis B InfectionGilead Sciences, Inc. $56,849.00Jan. 1, 2009
David L. Suskind, MDCurcumin in Pediatric Ulcerative colitis: A forced dose titration studyUniversity of Washington Institute for Translational Health Science $24,000July 2008 - Aug. 2009
Simon Horslen, MB ChBIntestinal failure in children: A contemporary retrospective review by the Pediatric Intestinal Failure ConsortiumNIHApril 1, 2008
Ghassan T. Wahbeh, MDA Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients with Inflammatory Bowel DiseaseCentocor $15911 2008
Karen Murray, MDClinical Research Network in Hepatitis B VirusNIH $311,878.00Jan. 1, 2008
Karen Murray, MDBARC CRN, Biliary atresia research consortiumNIH NIDDK $95,266.00Jan. 1, 2008
Simon Horslen, MB ChBA Multi-Center Group to Study Acute Liver Failure in ChildrenNIH/NIDDK Sept. 15, 2005
David L. Suskind, MDMaternal microchimerism in Inflammatory Bowel DiseaseBroad Foundation Medical Research Grant $142,000July 2005 - July 2007
Simon Horslen, MB ChB Studies in Pediatric Liver Transplantation NIHMay 6, 2005
Karen Murray, MDA phase 3 double-blind, randomized, placebo-controlled study of the safety and efficacy of Adefovir Dipivoxil in children and adolescents (age 2 to under 18) with chronic hepatitis BGilead Sciences, Inc. $128,327.00Jan. 1, 2004
Karen Murray, MDPegylated interferon + - ribavirin for children with HCVFDA-OPD-2002 Clinical Studies of Safety and Effectiveness of Orphan Products $99,650.00Jan. 1, 2003
David L. Suskind, MDMaternal microchimerism in Biliary AtresiaUniversity of California San Francisco of Medicine Research, Evaluation and Allocation Committee (REAC) Grant $16,000June 2002 - June 2003
Karen Murray, MDCD4+ T-cell immunity in mother-child pairs infected with hepatitis C virusResearch Endorsement Fund $30,000.00Jan. 1, 2002
Karen Murray, MDPediatric Acute liver failure study groupNIH/NIDDK $16,000.000101.05
David L. Suskind, MDFecal Microbial Therapy in Pediatric Crohn's DiseaseCuyamaca Foundation $$70,000
Academic Annual Report